Bluejay Diagnostics (BJDX) Competitors $1.80 -0.11 (-5.50%) As of 02:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. GCTK, HSCS, QNRX, VERO, NAOV, CTCX, TTOO, TIVC, BBLG, and NDRAShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include GlucoTrack (GCTK), Heart Test Laboratories (HSCS), Quoin Pharmaceuticals (QNRX), Venus Concept (VERO), NanoVibronix (NAOV), Carmell (CTCX), T2 Biosystems (TTOO), Tivic Health Systems (TIVC), Bone Biologics (BBLG), and ENDRA Life Sciences (NDRA). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. GlucoTrack Heart Test Laboratories Quoin Pharmaceuticals Venus Concept NanoVibronix Carmell T2 Biosystems Tivic Health Systems Bone Biologics ENDRA Life Sciences Bluejay Diagnostics (NASDAQ:BJDX) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends. Is BJDX or GCTK more profitable? Bluejay Diagnostics' return on equity of -155.67% beat GlucoTrack's return on equity.Company Net Margins Return on Equity Return on Assets Bluejay DiagnosticsN/A -155.67% -117.82% GlucoTrack N/A -826.43%-707.26% Does the media refer more to BJDX or GCTK? In the previous week, GlucoTrack had 4 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 4 mentions for GlucoTrack and 0 mentions for Bluejay Diagnostics. Bluejay Diagnostics' average media sentiment score of 0.69 beat GlucoTrack's score of 0.18 indicating that Bluejay Diagnostics is being referred to more favorably in the media. Company Overall Sentiment Bluejay Diagnostics Positive GlucoTrack Neutral Which has more risk & volatility, BJDX or GCTK? Bluejay Diagnostics has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, GlucoTrack has a beta of -0.14, suggesting that its share price is 114% less volatile than the S&P 500. Does the MarketBeat Community prefer BJDX or GCTK? Bluejay Diagnostics received 2 more outperform votes than GlucoTrack when rated by MarketBeat users. CompanyUnderperformOutperformBluejay DiagnosticsOutperform Votes266.67% Underperform Votes133.33% GlucoTrackN/AN/A Which has better earnings & valuation, BJDX or GCTK? GlucoTrack has lower revenue, but higher earnings than Bluejay Diagnostics. Bluejay Diagnostics is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBluejay Diagnostics$250K4.00-$9.95M-$379.740.00GlucoTrackN/AN/A-$7.10M-$56.600.00 Do institutionals and insiders have more ownership in BJDX or GCTK? 18.5% of Bluejay Diagnostics shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 0.4% of Bluejay Diagnostics shares are owned by insiders. Comparatively, 46.5% of GlucoTrack shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryBluejay Diagnostics beats GlucoTrack on 8 of the 12 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1M$4.50B$5.38B$8.42BDividend YieldN/A43.64%5.22%4.11%P/E Ratio0.0029.5826.6219.77Price / Sales4.0068.44392.02116.56Price / CashN/A51.0838.2534.62Price / Book0.006.256.814.53Net Income-$9.95M$68.16M$3.23B$248.18M7 Day Performance5.56%18.41%4.05%1.06%1 Month Performance5.56%23.13%11.64%14.68%1 Year Performance-99.12%20.79%17.11%6.87% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.1771 of 5 stars$1.81-5.5%N/A-99.1%$1M$250,000.000.009Positive NewsGap UpGCTKGlucoTrack0.9817 of 5 stars$0.15-4.1%N/A-99.7%$3.81MN/A0.005News CoveragePositive NewsEarnings ReportGap UpHSCSHeart Test Laboratories2.4391 of 5 stars$3.47+1.2%$13.00+274.6%-23.6%$3.75M$14,700.00-0.4410News CoverageGap UpQNRXQuoin Pharmaceuticals0.2187 of 5 stars$6.12-1.1%N/A-68.4%$3.60MN/A-1.514VEROVenus Concept1.1167 of 5 stars$2.49+2.5%N/A-66.5%$3.55M$64.83M-0.31410Positive NewsEarnings ReportNAOVNanoVibronix0.4651 of 5 stars$4.11-0.2%N/A-83.7%$3.40M$2.56M-3.3420Earnings ReportGap DownCTCXCarmellN/A$0.15-1.3%N/A+54.3%$3.20M$32,839.000.0014TTOOT2 BiosystemsN/A$0.15+11.5%$5.00+3,348.3%-97.3%$3.05M$7.68M0.00180Analyst ForecastTIVCTivic Health Systems0.0878 of 5 stars$4.23+7.4%N/A-45.5%$2.59M$780,000.000.0010Earnings ReportGap DownBBLGBone Biologics1.2916 of 5 stars$0.73-2.6%N/A-51.6%$2.39MN/A0.002Positive NewsNDRAENDRA Life Sciences1.683 of 5 stars$3.45+5.8%$50.00+1,349.3%-100.0%$1.94MN/A0.0020Gap Up Related Companies and Tools Related Companies GlucoTrack Alternatives Heart Test Laboratories Alternatives Quoin Pharmaceuticals Alternatives Venus Concept Alternatives NanoVibronix Alternatives Carmell Alternatives T2 Biosystems Alternatives Tivic Health Systems Alternatives Bone Biologics Alternatives ENDRA Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BJDX Stock Free BJDX Stock Alerts